This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: alirocumab

March 2017 Br J Cardiol 2017;24:15–16

In brief

BJCardio Staff

Abstract

A high-sensitivity blood test could be used to predict which patients are at risk of myocardial infarction according to new research funded by the British Heart Foundation (BHF) and carried out by the Universities of Glasgow and Edinburgh. The study, published recently in the Journal of the American College of Cardiology (doi: 10.1016/j.jacc.2016.10.020), shows the troponin test could also be a more effective way of assessing future heart disease risk than blood pressure or cholesterol. In the study of over 3,000 men with high cholesterol but no history of heart disease, the team found that changes in blood levels of a high-sensitivity tropon

| Full text

December 2015 Br J Cardiol 2015;22:143–4

In brief

BJCardio Staff

Abstract

BHF to spend half a billion pounds on research A new research strategy has been launched by the British Heart Foundation (BHF), aiming to fund over half a billion pounds of new cardiovascular research over the next five years. The BHF’s new strategy includes a commitment to continue funding the best researchers working across all areas of cardiovascular disease research.  This includes a pledge by the BHF to help women stay in research after a review highlighted the underrepresentation of women in senior cardiovascular research roles. Also, for the first time, the BHF will fund healthcare professionals, such as nurses, by establishing a de

| Full text

October 2015 Br J Cardiol 2015;22:138–142 Online First

News from the European Society of Cardiology Congress 2015

BJCardio Staff

Abstract

(more…)

| Full text

May 2015 Br J Cardiol 2015;22:59–60 Online First

News from the European Atherosclerosis Society Congress

BJCardio Staff

Abstract

FH initiative Headlining the Congress was the launch of the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC), a consortium of major FH registries across Europe, Asia-Pacific, Africa and South America, led by Professor Kausik Ray (Imperial College, London). As shown by the previous EAS Consensus Panel statement, FH is one of the most common inherited conditions, yet it is underdiagnosed and undertreated in almost all countries.1 The FHSC will provide information on key aspects relating to FH care which will be critical in leveraging public policy to improve detection and management. Linking patient and clinician empowerment unde

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now